Abstract
Dehydroepiandrosterone sulfate (DHEAS) is one of the most important neuroactive steroids. The present study examined the effect of DHEAS on spontaneous and evoked glutamate release in the pyramidal cells of layers V and VI of the rat prelimbic cortex by using whole-cell patch-clamp recordings in slices and further investigated its mechanism. The results showed that DHEAS at 1 μM had no effect on spontaneous glutamate release but inhibited 5-hydroxytryptaime (5-HT)-evoked glutamate release. The concentration-response relationship of this effect of DHEAS was U-shaped with a maximum at 1 μM, and this inhibition seemed to have some extent of selectivity for the 5-HT-evoked glutamate release because it had no effects on high K+-, electrical stimulus-, and dopamine-evoked releases. Further study showed that DHEAS inhibited the 5-HT3 receptor agonist evoked-glutamate release but had no effect on the 5-HT2A/2C receptor agonist-evoked release. Moreover, the 5-HT3 receptor antagonist could block the effect of DHEAS on the 5-HT-evoked glutamate release. The mechanism study showed that the σ-1 receptor antagonist could block the effect of DHEAS and that the σ-1 receptor agonist could mimic the effect of DHEAS on 5-HT3 receptor agonist-evoked glutamate release and intrasynaptosomal Ca2+ increase. These results suggest that DHEAS can inhibit 5-HT-evoked glutamate release via activation of the σ-1 receptor and then inhibition of the 5-HT3 receptor in the pyramidal cells of the prelimbic cortex.
Footnotes
-
This work was supported by the National Natural Science Foundation of China [Grants 30670653, 30821002]; the National Program of Basic Research sponsored by the Ministry of Science and Technology of China [Grant 2009CB52201]; and Project of Shanghai Leading Academic Discipline [Grant B119].
-
L.Y.D., Y.Z., and Y.D. are contributed equally to this work as first coauthors.
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.109.154294.
-
ABBREVIATIONS: DHEAS, dehydroepiandrosterone sulfate; 5-HT, 5-hydroxytryptamine; sEPSC, spontaneous excitatory postsynaptic current; PPF, paired-pulse facilitation; ACSF, artificial cerebrospinal fluid; EPSC, excitatory postsynaptic current; ANOVA, analysis of variance; DMSO, dimethyl sulfoxide; CPBG, 1-(m-chlorophenyl)-biguanide; AC915, 1-pyrrolidinylethyl 3,4-dichlorophenylacetate; DOI, 1-(2,5-dimethyl-4-iodophenyl)-2-aminopraopane; CB, carbetapentane; MDL72222, tropanyl 3,5-dichlorobenzoate; BD1047, N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(dimethylamino) ethylamine; NEM, N-ethylmaleimide.
-
↵1 Current affiliation: Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China.
- Received March 31, 2009.
- Accepted May 5, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
In this issue
Neuroactive Steroid Dehydroepiandrosterone Sulfate Inhibits 5-Hydroxytryptamine (5-HT)-Evoked Glutamate Release via Activation of σ-1 Receptors and Then Inhibition of 5-HT3 Receptors in Rat Prelimbic Cortex
